🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Lingsha Zhou

The University of Texas MD Anderson Cancer Center

ORCID: 0000-0002-7981-8766

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Single-center experience with venetoclax combinations in patients with newly diagnosed and relapsed AML evolving from MPNs”.

Single-center experience with venetoclax combinations in patients with newly diagnosed and relapsed AML evolving from MPNs

Blood Advances(2021)10.1182/bloodadvances.2020003934

N/A

0DataRank · unranked

48 citations

Courtney D. DiNardo, Prithviraj Bose, Naveen Pemmaraju, Naval Daver, Tapan M. Kadia +7 more

Characteristics of patients with myelofibrosis on ruxolitinib for three or more years.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.e19082

N/A

0DataRank · unranked

0 citations

Prithviraj Bose, Naveen Pemmaraju, Helen T. Chifotides, Lingsha Zhou, Zeev Estrov +3 more

Sotatercept for anemia of myelofibrosis: a phase II investigator-initiated study

Haematologica(2024)10.3324/haematol.2023.284078

N/A

0DataRank · unranked

15 citations

Lucia Masárová, Naveen Pemmaraju, Sharon Bledsoe, Naval Daver, Elias Jabbour +19 more